2. Natural Products
  3. Plants
  4. Polyporaceae
  5. Ganoderma lucidum (Leyss. Ex Fr.) Karst.

Ganoderma lucidum (Leyss. Ex Fr.) Karst.

Ganoderma lucidum (Leyss. Ex Fr.) Karst. (29):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N1447
    Ganoderic acid A 81907-62-2 99.84%
    Ganoderic acid A can inhibit of the JAK-STAT3 signaling pathway, also inhibit proliferation, viability, ROS.
    Ganoderic acid A
  • HY-N1511
    Ganoderic acid D 108340-60-9 99.40%
    Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis.
    Ganoderic acid D
  • HY-N1517
    Ganoderic acid C2 103773-62-2 99.72%
    Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses the potential anti-tumor bioactivity, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 is the inhibitor for aldose reductase with an IC50 of 43.8 µM.
    Ganoderic acid C2
  • HY-120140
    Ganoderic acid DM 173075-45-1 99.75%
    Ganoderic acid DM, a natural triterpenoid isolated from Ganoderma lucidum, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Ganoderic acid DM as a specific inhibitor of osteoclastogenesis.
    Ganoderic acid DM
  • HY-N6036
    Ganoderic acid F 98665-15-7 99.70%
    Ganoderic acid F is a ganoderic acid. Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/or cell death, carcinogenesis, oxidative stress, calcium signaling, and endoplasmic reticulum stress.
    Ganoderic acid F
  • HY-N1506
    Ganodermanontriol 106518-63-2
    Ganodermanontriol, a sterol isolated from Ganoderma lucidum, induces anti-inflammatory activity in tert-butyl hydroperoxide (t-BHP)-damaged hepatic cells through the expression of HO-1. Ganodermanontriol exhibits hepatoprotective activity.
    Ganodermanontriol
  • HY-N2006
    Ganoderic acid B 81907-61-1 99.60%
    Ganoderic acid B is a triterpene isolated from a mushroom Ganoderma lucidum. Ganoderic acid B inhibits the activation of Epstein-Barr virus (EBV) antigens as telomerase inhibitor. Ganoderic acid B is a moderately active inhibitor against HIV-1 protease (IC50: 170 μM).
    Ganoderic acid B
  • HY-N2221
    Ganoderal A 104700-98-3
    Ganoderal A, an oxygenated sterol from G. lucidum, is a cholesterol synthesis inhibitor.
    Ganoderal A
  • HY-107260
    Lucidenic acid D 98665-16-8 99.78%
    Lucidenic acid D (Lucidenic acid D2) is a highly oxidized lanostane-type triterpenoid, can inhibit the proliferation of HepG2 cells.
    Lucidenic acid D
  • HY-N2223
    Ganoderol B 104700-96-1
    Ganoderol B is a potent α-glucosidase inhibitor. Ganoderol B has high α-glucosidase inhibition with an IC50 of 48.5 μg/mL (119.8 μM).
    Ganoderol B
  • HY-N2996
    Ganodermanondiol 107900-76-5 99.24%
    Ganodermanondiol is a melanogenesis inhibitor isolated from the Ganoderma lucidum.Ganodermanondiol exhibits potent cytoprotective effects on tert-butyl hydroperoxide-induced hepatotoxicity. Ganodermanondiol shows significant anti-HIV-1 protease activity with an IC50 of 90 μM. Ganodermanondiol exhibits a strong anticomplement activity against the classical pathway of the complement system with an IC50 of 41.7μM.
    Ganodermanondiol
  • HY-N1512
    Ganoderic acid E 98665-14-6 99.30%
    Ganoderic acid E is a triterpenoid found in Ganoderma lucidum.
    Ganoderic acid E
  • HY-N1516
    Ganoderenic acid D 100665-43-8 99.51%
    Ganoderenic acid D is a triterpene identified from the effective compounds of Ganoderma lucidum extract (GLE). Ganoderenic acid D inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis.
    Ganoderenic acid D
  • HY-129151
    Ganoderic acid C1 95311-97-0
    Ganoderic acid C1, a natural compound that could be isolated from G. lucidum, suppresses TNF-α production by murine macrophages (RAW 264.7 cells).
    Ganoderic acid C1
  • HY-129150
    Ganoderic acid TR 862893-75-2 98.0%
    Ganoderic acid TR is a broad-spectrum inhibitor of influenza neuraminidase enzymes (NAs). Ganoderic acid TR has IC50 values of 10.9 and 4.6 μM for H5N1 and H1N1 NAs, respectively. Ganoderic acid TR is limited by cytotoxicity and shows only weak activity against Oseltamivir (HY-13317)-resistant H1N1 viruses and influenza B viruses.
    Ganoderic acid TR
  • HY-N1515
    Ganoderenic acid C 100665-42-7 99.87%
    Ganoderenic acid C is a triterpenoid isolated from Ganoderma lingzhi. Ganoderenic acid C is abundant in fruit bodies at an early growth stage.
    Ganoderenic acid C
  • HY-N1447R
    Ganoderic acid A (Standard) 81907-62-2
    Ganoderic acid A (Standard) is the analytical standard of Ganoderic acid A. This product is intended for research and analytical applications. Ganoderic acid A can inhibit of the JAK-STAT3 signaling pathway, also inhibit proliferation, viability, ROS.
    Ganoderic acid A (Standard)
  • HY-N1517A
    (Rac)-Ganoderic acid C2 98296-48-1
    (Rac)-Ganoderic acid C2 is the racemate of Ganoderic acid C2 (HY-N1517). Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses anti-tumor, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 exhibits high inhibitory activity against the rat lens aldose reductase (RLAR) with an IC50 of 3.8 µM[.
    (Rac)-Ganoderic acid C2
  • HY-N1514R
    Ganoderenic acid B (Standard) 100665-41-6
    Doxylamine (succinate) (Standard) is the analytical standard of Doxylamine (succinate). This product is intended for research and analytical applications. Doxylamine (succinate), a first generation antihistamine, is a histamine (H1) receptor antagonist. Doxylamine is also a local analgesic agent and effective hypnotic agent.
    Ganoderenic acid B (Standard)
  • HY-123100R
    Ganoderic acid N (Standard) 110241-19-5
    Isoxepac (Standard) is the analytical standard of Isoxepac. This product is intended for research and analytical applications. Isoxepac (HP 549) is a nonsteroidal anti-inflammatory agent (NSAID) with anti-inflammatory, analgesic and antipyretic activity. Isoxepac has been studied in rat, rabbit, dog, rhesus monkey, etc.
    Ganoderic acid N (Standard)